Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000874015-20-000002
Filing Date
2020-01-03
Accepted
2020-01-03 18:47:10
Documents
1
Period of Report
2020-01-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2293
  Complete submission text file 0000874015-20-000002.txt   3732
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address
Swayze Eric (Reporting) CIK: 0001791058 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19125 | Film No.: 20507493